You are here: Industry Insights > GlobalData

News List

CMOs should invest in biologic API manufacturing capabilities, says GlobalData europeanpharmaceuticalreview
May 14, 2021
Research shows the complexity and number of biologics is increasing, as is the frequency at which their active pharmaceutical ingredient (API) production is outsourced.
Roche’s antibody cocktail for COVID-19 may face affordability issues in India: GlobalData expresspharma
May 08, 2021
Following the news that Roche has received emergency use authorization (EUA) for a COVID-19 antibody cocktail casirivimab and imdevimab; Prashant Khadayate, Pharma Analyst at GlobalData offers his view.
COVID-19 manufacturing requirements are lucrative for CMOs, says GlobalData europeanpharmaceuticalreview
May 06, 2021
A new report shows half the drugs and all the vaccines approved for emergency use in 2020 had an associated contract manufacturing agreement.
CMOs gain advantages of COVID-19 production and timescale demands: GlobalData expresspharma
May 06, 2021
CMOs signed contract manufacturing service agreements at an unprecedented rate in 2020, says GlobalData.
Pharma industry investments in blockchain decreased in 2020: GlobalData expresspharma
April 29, 2021
Nevertheless, respondents across all geographies believed that investments in blockchain should pick up in the next two years.
India should step up vaccination rate, enable oxygen supplies to control COVID-19 pandemic: GlobalData expresspharma
April 27, 2021
A novel ‘double mutant’ variant of SARS-CoV-2, along with other factors, has accelerated the COVID-19 pandemic in India, setting a global record of new daily cases.
Pancreatic cancer market to reach $4.1 billion by 2029: GlobalData expresspharma
April 26, 2021
Growth in pancreatic cancer therapy market will be driven by the introduction of drugs with novel mechanisms of action, across several lines of therapies, which are poised to meet high unmet need in the US and 5EU.
Monoclonal antibodies against COVID-19 have high potential, but efficacy against emerging variants muddled: GlobalData expresspharma
April 23, 2021
The prevalence of more transmissible strains is growing fast and may require adjustments to current therapies to ensure they retain clinical efficacy.
Chinese checkpoint inhibitors may drive down drug prices: GlobalData expresspharma
April 19, 2021
International brands seeking access in China should balance diminishing drug prices with the opportunity to target enormous patient pool.
COVID-19 survivors may face long-term complications: GlobalData expresspharma
April 14, 2021
Further follow-up on the long-term effects of the disease needs to be conducted, along with treatments to prevent these outcomes.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page